Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer's disease. 2018

Panagiotis Alexopoulos, and Lena-Sophie Gleixner, and Lukas Werle, and Felix Buhl, and Nathalie Thierjung, and Evangelia Giourou, and Simone M Kagerbauer, and Philippos Gourzis, and Hubert Kübler, and Timo Grimmer, and Igor Yakushev, and Jan Martin, and Alexander Kurz, and Robert Perneczky
Department of Psychiatry and Psychotherapy, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany. panos.alexopoulos@upatras.gr.

The established biomarkers of Alzheimer's disease (AD) require invasive endeavours or presuppose sophisticated technical equipment. Consequently, new biomarkers are needed. Here, we report that plasma levels of soluble amyloid precursor protein β (sAPPβ), a protein of the initial phase of the amyloid cascade, were significantly lower in patients with symptomatic AD (21 with mild cognitive impairment due to AD and 44 with AD dementia) with AD-typical cerebral hypometabolic pattern compared with 27 cognitively healthy elderly individuals without preclinical AD. These findings yield further evidence for the potential of sAPPβ in plasma as an AD biomarker candidate.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D016564 Amyloid beta-Protein Precursor A single-pass type I membrane protein. It is cleaved by AMYLOID PRECURSOR PROTEIN SECRETASES to produce peptides of varying amino acid lengths. A 39-42 amino acid peptide, AMYLOID BETA-PEPTIDES is a principal component of the extracellular amyloid in SENILE PLAQUES. Amyloid A4 Protein Precursor,Amyloid Protein Precursor,beta-Amyloid Protein Precursor,Amyloid beta Precursor Protein,Protease Nexin 2,Protease Nexin II,Amyloid beta Protein Precursor,Nexin 2, Protease,Nexin II, Protease,beta Amyloid Protein Precursor,beta-Protein Precursor, Amyloid
D060825 Cognitive Dysfunction Diminished or impaired mental and/or intellectual function. Cognitive Disorder,Mild Cognitive Impairment,Cognitive Decline,Cognitive Impairments,Mental Deterioration,Cognitive Declines,Cognitive Disorders,Cognitive Dysfunctions,Cognitive Impairment,Cognitive Impairment, Mild,Cognitive Impairments, Mild,Decline, Cognitive,Declines, Cognitive,Deterioration, Mental,Deteriorations, Mental,Disorder, Cognitive,Disorders, Cognitive,Dysfunction, Cognitive,Dysfunctions, Cognitive,Impairment, Cognitive,Impairment, Mild Cognitive,Impairments, Cognitive,Impairments, Mild Cognitive,Mental Deteriorations,Mild Cognitive Impairments

Related Publications

Panagiotis Alexopoulos, and Lena-Sophie Gleixner, and Lukas Werle, and Felix Buhl, and Nathalie Thierjung, and Evangelia Giourou, and Simone M Kagerbauer, and Philippos Gourzis, and Hubert Kübler, and Timo Grimmer, and Igor Yakushev, and Jan Martin, and Alexander Kurz, and Robert Perneczky
January 2020, Archives of gerontology and geriatrics,
Panagiotis Alexopoulos, and Lena-Sophie Gleixner, and Lukas Werle, and Felix Buhl, and Nathalie Thierjung, and Evangelia Giourou, and Simone M Kagerbauer, and Philippos Gourzis, and Hubert Kübler, and Timo Grimmer, and Igor Yakushev, and Jan Martin, and Alexander Kurz, and Robert Perneczky
June 2013, Brain research,
Panagiotis Alexopoulos, and Lena-Sophie Gleixner, and Lukas Werle, and Felix Buhl, and Nathalie Thierjung, and Evangelia Giourou, and Simone M Kagerbauer, and Philippos Gourzis, and Hubert Kübler, and Timo Grimmer, and Igor Yakushev, and Jan Martin, and Alexander Kurz, and Robert Perneczky
February 2013, Translational psychiatry,
Panagiotis Alexopoulos, and Lena-Sophie Gleixner, and Lukas Werle, and Felix Buhl, and Nathalie Thierjung, and Evangelia Giourou, and Simone M Kagerbauer, and Philippos Gourzis, and Hubert Kübler, and Timo Grimmer, and Igor Yakushev, and Jan Martin, and Alexander Kurz, and Robert Perneczky
June 2011, Journal of neuroscience research,
Panagiotis Alexopoulos, and Lena-Sophie Gleixner, and Lukas Werle, and Felix Buhl, and Nathalie Thierjung, and Evangelia Giourou, and Simone M Kagerbauer, and Philippos Gourzis, and Hubert Kübler, and Timo Grimmer, and Igor Yakushev, and Jan Martin, and Alexander Kurz, and Robert Perneczky
June 2017, Cold Spring Harbor perspectives in medicine,
Panagiotis Alexopoulos, and Lena-Sophie Gleixner, and Lukas Werle, and Felix Buhl, and Nathalie Thierjung, and Evangelia Giourou, and Simone M Kagerbauer, and Philippos Gourzis, and Hubert Kübler, and Timo Grimmer, and Igor Yakushev, and Jan Martin, and Alexander Kurz, and Robert Perneczky
June 1993, Neuroreport,
Panagiotis Alexopoulos, and Lena-Sophie Gleixner, and Lukas Werle, and Felix Buhl, and Nathalie Thierjung, and Evangelia Giourou, and Simone M Kagerbauer, and Philippos Gourzis, and Hubert Kübler, and Timo Grimmer, and Igor Yakushev, and Jan Martin, and Alexander Kurz, and Robert Perneczky
March 2004, Brain research. Molecular brain research,
Panagiotis Alexopoulos, and Lena-Sophie Gleixner, and Lukas Werle, and Felix Buhl, and Nathalie Thierjung, and Evangelia Giourou, and Simone M Kagerbauer, and Philippos Gourzis, and Hubert Kübler, and Timo Grimmer, and Igor Yakushev, and Jan Martin, and Alexander Kurz, and Robert Perneczky
January 2012, Journal of Alzheimer's disease : JAD,
Panagiotis Alexopoulos, and Lena-Sophie Gleixner, and Lukas Werle, and Felix Buhl, and Nathalie Thierjung, and Evangelia Giourou, and Simone M Kagerbauer, and Philippos Gourzis, and Hubert Kübler, and Timo Grimmer, and Igor Yakushev, and Jan Martin, and Alexander Kurz, and Robert Perneczky
July 1992, Annals of neurology,
Panagiotis Alexopoulos, and Lena-Sophie Gleixner, and Lukas Werle, and Felix Buhl, and Nathalie Thierjung, and Evangelia Giourou, and Simone M Kagerbauer, and Philippos Gourzis, and Hubert Kübler, and Timo Grimmer, and Igor Yakushev, and Jan Martin, and Alexander Kurz, and Robert Perneczky
October 2014, Annals of neurology,
Copied contents to your clipboard!